Wu H, Chen S, Li A, Shen K, Wang S, Wang S, et al. LncRNA expression profiles in systemic lupus erythematosus and rheumatoid arthritis: emerging biomarkers and therapeutic targets. Front Immunol. 2021;12: 792884. https://doi.org/10.3389/fimmu.2021.792884.

Article  CAS  PubMed Central  Google Scholar 

Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, et al. Parthenolide, an NF-kappaB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-beta/Smad pathway. Int Immunopharmacol. 2020;78: 106064. https://doi.org/10.1016/j.intimp.2019.106064.

Article  CAS  Google Scholar 

Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017;56(11):1945–61. https://doi.org/10.1093/rheumatology/kex260.

Article  Google Scholar 

Illescas-Montes R, Corona-Castro CC, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology. 2019;158(3):153–60. https://doi.org/10.1111/imm.13103.

Article  CAS  PubMed Central  Google Scholar 

Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16(5):527–38. https://doi.org/10.1080/1744666X.2020.1763793.

Article  CAS  Google Scholar 

Rao M, Mikdashi J. A framework to overcome challenges in the management of infections in patients with systemic lupus erythematosus. Open Access Rheumatol. 2023;15:125–37. https://doi.org/10.2147/OARRR.S295036.

Article  PubMed Central  Google Scholar 

Ko T, Koelmeyer R, Li N, Yap K, Yeo AL, Kent J, et al. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum. 2022;57: 152099. https://doi.org/10.1016/j.semarthrit.2022.152099.

Article  Google Scholar 

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, et al. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national. Latin American lupus cohort Lupus. 2019;28(9):1101–10. https://doi.org/10.1177/0961203319860579.

Article  CAS  Google Scholar 

Li G, Liu X, Zhao J. Clinical characteristics, microbiological and risk factors of infections in patients with systemic lupus erythematosus. J Community Hosp Intern Med Perspect. 2025;15(1):36–41. https://doi.org/10.55729/2000-9666.1447.

Article  CAS  PubMed Central  Google Scholar 

Kim MH, Choi SR, Park JK, Lee EY, Lee EB, Park JW. Risk of bloodstream infection in patients with systemic lupus erythematosus exposed to prolonged medium-to-high-dose glucocorticoids. Lupus. 2023;32(5):625–32. https://doi.org/10.1177/09612033231160731.

Article  CAS  Google Scholar 

Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81-ITC96. https://doi.org/10.7326/AITC202006020.

Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(1):60–72. https://doi.org/10.1093/rheumatology/keaa478.

Article  Google Scholar 

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis & rheumatology (Hoboken, NJ). 2019;71(9):1400–12. https://doi.org/10.1002/art.40930.

Article  Google Scholar 

Lam F, Mok CC. Disease activity indices in systemic lupus erythematosus: what is new? Journal of Clinical Rheumatology and Immunology. 2023;23(02):60–7. https://doi.org/10.1142/s2661341723300057.

Article  Google Scholar 

Abe K, Ishikawa Y, Kita Y, Yajima N, Inoue E, Sada KE, et al. Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study. Arthritis Res Ther. 2022;24(1):179. https://doi.org/10.1186/s13075-022-02869-9.

Article  CAS  PubMed Central  Google Scholar 

Calabrese C, Atefi G, Evans KA, Moynihan M, Palmer L, Wu SJ. Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020–2021. RMD Open. 2023;9(3). https://doi.org/10.1136/rmdopen-2023-003250.

Chang YS, Chang CC, Chen YH, Chen WS, Chen JH. Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study. Lupus. 2017;26(11):1149–56. https://doi.org/10.1177/0961203317694260.

Article  CAS  Google Scholar 

Chen D, Li H, Xie J, Zhan Z, Liang L, Yang X. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Ther Med. 2017;14(6):6222–8. https://doi.org/10.3892/etm.2017.5297.

Article  CAS  PubMed Central  Google Scholar 

Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, et al. Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43(9):1650–6. https://doi.org/10.3899/jrheum.151523.

Article  CAS  Google Scholar 

Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015;67(6):1577–85. https://doi.org/10.1002/art.39070.

Article  PubMed Central  Google Scholar 

Gonzalez-Naranjo LA, Coral-Enriquez JA, Restrepo-Escobar M, Munoz-Vahos CH, Jaramillo-Arroyave D, Vanegas-Garcia AL, et al. Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study. Clin Rheumatol. 2021;40(1):181–91. https://doi.org/10.1007/s10067-020-05225-x.

Article  Google Scholar 

Hou C, Jin O, Zhang X. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus. Clin Rheumatol. 2018;37(10):2699–705. https://doi.org/10.1007/s10067-018-4198-8.

Article  Google Scholar 

Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek JH, et al. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis. 2009;41(4):268–74. https://doi.org/10.1080/00365540902744741.

Article  Google Scholar 

Jung JY, Yoon D, Choi Y, Kim HA, Suh CH. Associated clinical factors for serious infections in patients with systemic lupus erythematosus. Sci Rep. 2019;9(1):9704. https://doi.org/10.1038/s41598-019-46039-5.

Article  CAS  PubMed Central  Google Scholar 

Juthong S, Geater AF, Dekumyoy P, Hortiwakul T, Siripaitoon B, Aiewruengsurat D, et al. Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand. Lupus. 2020;29(6):539–46. https://doi.org/10.1177/0961203320911091.

Article  CAS  Google Scholar 

Lao M, Wang X, Ding M, Yang Z, Chen H, Liang L, et al. Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study. Lupus. 2019;28(1):77–85. https://doi.org/10.1177/0961203318817118.

Article  CAS  Google Scholar 

Li TH, Lai CC, Wang WH, Chen WS, Tsao YP, Tsai CY, et al. Risk of severe herpes simplex virus infection in systemic lupus erythematosus: analysis of epidemiology and risk factors analysis in Taiwan. Ann Rheum Dis. 2019;78(7):941–6. https://doi.org/10.1136/annrheumdis-2018-214844.

Article  Google Scholar 

Merayo-Chalico J, Gómez-Martín D, Piñeirúa-Me néndez A, Santana-De Anda K, Alcocer-Varela J. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM : monthly journal of the Association of Physicians. 2013;106(5):451–7. https://doi.org/10.1093/qjmed/hct046.

Patil A, Shobha V, Shenoy P, S C, Kumar S, Daware M et al. Risk factors associated with COVID-19 in systemic lupus erythematosus: results from a longitudinal prospective cohort. Lupus. 2023;32(4):560–4. https://doi.org/10.1177/09612033231155837.

Peng L, Wang Y, Zhao L, Chen T, Huang A. Severe pneumonia in Chinese patients with systemic lupus erythematosus. Lupus. 2020;29(7):735–42. https://doi.org/10.1177/0961203320922609.

Article  CAS  Google Scholar 

Rua-Figueroa I, Lopez-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, et al. Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: risk factors, clinical and microbiological characteristics, and outcomes. J Rheumatol. 2020;47(2):234–40. https://doi.org/10.3899/jrheum.180882.

Article  CAS  Google Scholar 

Santamaria-Alza Y, Sanchez-Bautista J, Fajardo-Rivero JF, Figueroa CL. Invasive fungal infections in Colombian patients with systemic lupus erythematosus. Lupus. 2018;27(7):1116–22. https://doi.org/10.1177/0961203318763743.

Article  CAS  Google Scholar 

Shi LH, Huang JY, Liu YZ, Chiou JY, Wu R, Wei JC. Risk of systemic lupus erythematosus in patients with human papillomavirus infection: a population-based retrospective cohort study. Lupus. 2018;27(14):2279–83. https://doi.org/10.1177/0961203318809179.

Article  Google Scholar 

Wang M, Zhang H, Yang X, Li W, Li T, Liu S. Laboratory-confirmed bloodstream infection in systemic lupus erythematosus: risk profiling and short-term mortality. Lupus. 2020;29(12):1520–7. https://doi.org/10.1177/0961203320948964.

Article  CAS  Google Scholar 

Zhang L, Zou X, Jiang N, Xie L, Liu J, Yang Z, et al. Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study. Front Immunol. 2023;14:1157157. https://doi.org/10.3389/fimmu.2023.1157157.